FAH anticorps (N-Term)
Aperçu rapide pour FAH anticorps (N-Term) (ABIN952405)
Antigène
Voir toutes FAH AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 14-41, N-Term
-
Specificité
- This antibody recognizes Human Fumarylacetoacetase (N-term).
-
Purification
- Affinity Chromatography on Protein A
-
Immunogène
- KLH conjugated synthetic peptide between 14-41 amino acids from the N-terminal region of human FAH
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- FAH (Fumarylacetoacetate Hydrolase (Fumarylacetoacetase) (FAH))
-
Autre désignation
- Fumarylacetoacetase
-
Sujet
- This gene encodes the last enzyme in the tyrosine catabolism pathway. FAH deficiency is associated with Type 1 hereditary tyrosinemia (HT).Synonyms: Beta-diketonase, FAA, FAH, Fumarylacetoacetate hydrolase
-
Poids moléculaire
- 46374 Da
-
ID gène
- 2184
-
NCBI Accession
- NP_000128
Antigène
-